Waystar Holding Corp. (WAY) Covered Calls

Waystar Holding Corp. is a leading provider of healthcare payment software, offering a cloud-native platform that simplifies the revenue cycle for medical providers. The company utilizes advanced AI and machine learning to automate financial clearance, claim management, and denial prevention. By unifying clinical, administrative, and financial data, Waystar helps healthcare organizations reduce labor costs, increase reimbursement accuracy, and improve the overall patient financial experience.

You can sell covered calls on Waystar Holding Corp. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for WAY (prices last updated Tue 4:16 PM ET):

Waystar Holding Corp. (WAY) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
25.23 +0.88 23.42 25.40 3.6M 40 4.7
Covered Calls For Waystar Holding Corp. (WAY)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Mar 20 25 1.40 24.00 4.2% 61.3%
Apr 17 25 1.90 23.50 6.4% 44.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Waystar Holding Corp. (WAY) is a premier healthcare technology firm providing mission-critical revenue cycle management (RCM) solutions. Headquartered in Lehi, Utah, and Louisville, Kentucky, the company serves over 30,000 clients, including prominent health systems and over one million distinct providers. Its business model centers on a cloud-based Software-as-a-Service (SaaS) platform that automates the complex journey of a healthcare claim—from pre-service eligibility verification to post-service payment reconciliation. By processing over 7.5 billion transactions annually, Waystar leverages a massive data network covering approximately 60% of U.S. patients.

The company’s technological backbone is its AltitudeAI engine, which utilizes a decade of transaction data to drive predictive analytics. In early 2026, Waystar reached a major milestone by introducing "Agentic AI" capabilities. This next-generation autonomous system does not just identify errors; it actively interacts within workflows to pre-populate clinical appeals and automatically correct coding discrepancies. These advancements are designed to combat the industry-wide rise in claim denials and alleviate administrative burnout by reducing manual workloads by approximately 40% for hospital staff.

Competitive Landscape

The competitive landscape for Waystar consists of legacy RCM providers and modern health-fintech firms. Primary rivals that are publicly traded on the NYSE or NASDAQ and offer active options markets include Doximity, Inc. and Phreesia, Inc.. These companies compete for market share in the digital transformation of provider-patient and provider-payer interactions.

Other notable competitors in the healthcare information services and diversified technology sectors with active options trading include CVS Health Corporation (via its Signify and provider-services units) and Alphabet Inc. (competing via Google Health analytics). Waystar distinguishes itself through its independent, "payer-agnostic" stance and its recent high-profile acquisition of Iodine Software, which integrated deep clinical data into its financial models. This combination of clinical and financial intelligence creates a significant moat against traditional billing services that lack deep clinical context.

Strategic Outlook

Strategic innovation is currently focused on achieving a "fully autonomous revenue cycle" where the majority of administrative tasks are handled by AI agents. By early 2026, the company has targeted a 17% revenue growth rate, supported by its successful integration of clinical data assets. Management is prioritizing the expansion of its platform into the mid-market and ambulatory segments, aiming to replicate the success it has seen with large enterprise health systems. These efforts are expected to drive higher net revenue retention and increase the adoption of high-margin AI modules.

The outlook involves a disciplined approach to capital allocation, with a focus on deleveraging the balance sheet following its 2024 IPO and subsequent acquisitions. In February 2026, the company reiterated its commitment to expanding adjusted EBITDA margins toward the 42% range by realizing cost synergies and leveraging its "build-once, deploy-many" SaaS architecture. By maintaining a 99% clean claim rate for its clients and continuing to lead independent satisfaction surveys, Waystar aims to solidify its position as the indispensable operating system for the modern healthcare economy.